NL-OMON55459
Recruiting
Phase 3
Protocol for treatment of children and adolescents with acute myeloid leukemia 0-18 years - NOPHO-DBH AML 2012 Protocol
Västra Götalandregionen, Queen Silvias Childrens and Adolescents Hospital0 sites150 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- bloodcancer
- Sponsor
- Västra Götalandregionen, Queen Silvias Childrens and Adolescents Hospital
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients are eligible for the study if they fulfil all three criteria below, 1\)
- •AML as defined by the diagnostic criteria in section 16
- •2\) Age \< 19 years at time of diagnosis
- •3\) Written informed consent
Exclusion Criteria
- •Patients are excluded if any of the criteria below are present
- •1\) Previous chemotherapy or radiotherapy.
- •2\) AML secondary to previous bone marrow failure syndrome.
- •3\) Down syndrome (DS).
- •4\) Acute promyelocytic leukaemia (APL).
- •5\) Myelodysplastic syndrome (MDS).
- •6\) Juvenile Myelomonocytic Leukaemia (JMML).
- •7\) Known intolerance to any of the chemotherapeutic drugs in the protocol.
- •8\) Fanconi anaemia.
- •9\) Major organ failure precluding administration of planned chemotherapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A study to keep a systematic watch over the treatment of the children and adolescent patients diagnosed with Chronic Myeloid Leukemia (CML) (a type of blood cancer) and to modify the frequency of treatment for the sameHealth Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positiveCTRI/2020/11/029199Dr Nirmalya Roy Moulik
Recruiting
N/A
A study to observe and record health related and disease related parameters of the children who prospectively receiving treatment for Chronic Myeloid Leukemia (CML)(a type of blood cancer), also considering to study the results of interruption of the chemotherapy in these patients.Health Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positiveCTRI/2020/03/023699Tata Memorial Hospital
Active, Not Recruiting
N/A
TREATMENT STUDY FOR CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - ICC APL STUDY 01EUCTR2008-002311-40-ITA.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA300
Active, Not Recruiting
Phase 1
OPHO - ALL 2008. Treatment Protocol for Children (1.0 - 17.9 years of age) with Acute Lymphoblastic Leukemia - NOPHO ALL-2008AEUCTR2008-003235-20-ISandspítali Háskólasjúkrahús1,550
Active, Not Recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaEUCTR2017-002383-40-ITAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90